BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$156M |
| 2 |
SPDR Gold Trust
GLD
|
+$142M |
| 3 |
Bank of America
BAC
|
+$107M |
| 4 |
iShares MSCI Brazil ETF
EWZ
|
+$92.9M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.53B |
| 2 |
Equinix
EQIX
|
+$2B |
| 3 |
Gilead Sciences
GILD
|
+$1.63B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.48B |
| 5 |
United Therapeutics
UTHR
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.55% |
| 2 | Technology | 24.39% |
| 3 | Consumer Discretionary | 8.23% |
| 4 | Materials | 5.85% |
| 5 | Real Estate | 5.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EMBJ
1326
Embraer S.A. ADS
EMBJ
$13.2B
| $390K | ﹤0.01% |
12,119
+2,051
| +20% | +$65.1K |
|
|
CHK
1327
CALL
DELISTED
Chesapeake Energy Corporation
CHK
| $389K | ﹤0.01% |
+2
| New | +$10.2K |
|
1328
Banco Santander
SAN
$211B
| $388K | ﹤0.01% |
47,080
-6,396
| -12% | -$50.8K |
|
1329
Bausch Health
BHC
$2.37B
| $387K | ﹤0.01% |
+3,300
| New | +$362K |
|
|
NIHD
1330
DELISTED
NII HOLDINGS INC CL B
NIHD
| $387K | ﹤0.01% |
140,827
+14,222
| +11% | +$52.4K |
|
1331
Teradyne
TER
$64.2B
| $387K | ﹤0.01% |
21,960
-79,577
| -78% | -$1.34M |
|
1332
Cohen & Steers Closed End Opportunity Fund
FOF
$380M
| $386K | ﹤0.01% |
+30,700
| New | +$382K |
|
|
HQH
1333
abrdn Healthcare Investors
HQH
$1.34B
| $385K | ﹤0.01% |
+14,602
| New | +$358K |
|
|
CA
1334
CALL
DELISTED
CA, Inc.
CA
| $383K | ﹤0.01% |
450
| – | – |
|
1335
CALL
TotalEnergies
TTE
$193B
| $379K | ﹤0.01% |
1,281,521,480
-1,193,468,349
| -48% | -$119K |
|
|
ITC
1336
DELISTED
ITC HOLDINGS CORP
ITC
| $379K | ﹤0.01% |
+11,868
| New | +$379K |
|
1337
CALL
State Street Materials Select Sector SPDR ETF
XLB
$8.57B
| $376K | ﹤0.01% |
7,560
-2,276
| -23% | -$50K |
|
|
SFG
1338
DELISTED
STANCORP FINL GRP
SFG
| $376K | ﹤0.01% |
+5,670
| New | +$349K |
|
1339
PUT
Goldman Sachs
GS
$304B
| $372K | ﹤0.01% |
3,111
-756
| -20% | -$125K |
|
1340
PUT
ExxonMobil
XOM
$652B
| $370K | ﹤0.01% |
9,299
-436
| -4% | -$40.3K |
|
1341
CALL
Duke Energy
DUK
$97.1B
| $369K | ﹤0.01% |
708
-996
| -58% | -$69.7K |
|
|
TWO
1342
Two Harbors Investment
TWO
$1.27B
| $367K | ﹤0.01% |
4,942
+2,697
| +120% | +$202K |
|
|
CELG
1343
CALL
DELISTED
Celgene Corp
CELG
| $366K | ﹤0.01% |
100
| – | – |
|
1344
CALL
Nike
NKE
$61.2B
| $364K | ﹤0.01% |
1,286
-3,080
| -71% | -$118K |
|
|
MR
1345
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
| $364K | ﹤0.01% |
10,001
-10,630
| -52% | -$413K |
|
1346
NVR
NVR
$16.8B
| $363K | ﹤0.01% |
+354
| New | +$336K |
|
1347
Associated Banc-Corp
ASB
$6.07B
| $363K | ﹤0.01% |
+20,856
| New | +$347K |
|
|
DFT
1348
DELISTED
DuPont Fabros Technology Inc.
DFT
| $362K | ﹤0.01% |
14,652
-13,735
| -48% | -$334K |
|
|
GOLD
1349
DELISTED
Randgold Resources Ltd
GOLD
| $359K | ﹤0.01% |
5,804
-54,622
| -90% | -$3.75M |
|
1350
Chemed
CHE
$7.02B
| $358K | ﹤0.01% |
4,667
-568
| -11% | -$41.9K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2013 Portfolio in Review
As of Q4 2013, BNP Paribas Financial Markets held 4,298 positions worth $137B, down 0.25% from $137B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
BNP Paribas Financial Markets withdrew a net $60.2B in Q4 2013, closing 193 positions and reducing 1,811 holdings. Its most notable exit was Innoviva, an estimated $182M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, BNP Paribas Financial Markets opened a new position in Ambev worth $22.5M.
- BNP Paribas Financial Markets's largest Q4 2013 buy was Ambev: 3,066,560 shares worth $22.5M.
- BNP Paribas Financial Markets added most to Apple in Q4 2013, an estimated $156M increase.
- BNP Paribas Financial Markets's biggest Q4 2013 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.53B.
- BNP Paribas Financial Markets fully exited Innoviva in Q4 2013, selling an estimated $182M.
- BNP Paribas Financial Markets's ten largest holdings make up 38% of its $137B portfolio in Q4 2013.
- BNP Paribas Financial Markets opened 1,712 new positions and closed 193 in Q4 2013.
- BNP Paribas Financial Markets's portfolio value fell 0.25% quarter-over-quarter to $137B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2013, filed 12 Feb 2014.